Literature DB >> 9725780

Bone density and skeletal metabolism are altered in idiopathic hypercalciuria.

S Giannini1, M Nobile, L Sartori, L Calò, A Tasca, L Dalle Carbonare, M Ciuffreda, A D'Angelo, F Pagano, G Crepaldi.   

Abstract

OBJECTIVE: To study bone density in hypercalciuric patients, when classified according to the main metabolic defect.
METHODS: We studied 49 patients, aged 19-60 years with calcium stones and idiopathic hypercalcuria. All subjects underwent an evaluation of mineral metabolism and a spinal and femoral DEXA measurement. Then, patients were classified as having Fasting (FH, 31 subjects) or Absorptive (AH, 18 patients) Hypercalciuria according to a standard oral calcium load.
RESULTS: Spinal bone density was lower only in FH patients as compared to controls (p <0.001). Bone alkaline phosphatase and urine hydroxyproline were higher with respect to controls only in patients with FH (p <0.005 and p <0.015, respectively). After low calcium diet, hydroxyproline excretion continued to be higher in FH patients (p <0.05). Although in the normal range, serum and urine uric acid were higher in hypercalciuric subjects (p <0.03 and p <0.005, respectively); blood pH was lower in hypercalciuric patients than in controls (p <0.01). In FH patients urine hydroxyproline negatively correlated with spinal and femoral density (p <0.001 and p <0.005, respectively), and blood pH positively correlated with spinal density.
CONCLUSIONS: a disordered bone metabolism and bone loss are present only in patients with fasting hypercalciuria. An excessive acid load, possibly of dietary origin, might be involved as a pathogenetic factor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725780

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  18 in total

Review 1.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

2.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

3.  Idiopathic hypercalciuria: O2(-)NO relationship and altered bone metabolism.

Authors:  L Calò; S Giannini; P Bonvicini; M Nobile; S Cantaro; M Plebani; A Semplicini; A D'Angelo; G Crepaldi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

Review 4.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

5.  Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers.

Authors:  F Vescini; A Buffa; G La Manna; A Ciavatti; E Rizzoli; A Bottura; S Stefoni; R Caudarella
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

6.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

7.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

8.  Relationship between renal stone formation, mitral annular calcification and bone resorption markers.

Authors:  Ahmet Celik; Vedat Davutoglu; Kemal Sarica; Sakip Erturhan; Orhan Ozer; Ibrahim Sari; Mustafa Yilmaz; Yasemin Baltaci; Murat Akcay; Behcet Al; Murat Yuce; Necat Yilmaz
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

9.  Osteopenia/osteoporosis in patients with calcium nephrolithiasis.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Maria Sierra Girón-Prieto; Antonio Poyatos-Andujar; Juan Garrido-Gomez; Armando Zuluaga-Gomez; Salvador Arias-Santiago
Journal:  Urol Res       Date:  2012-08-12

10.  Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

Authors:  Michael Freundlich; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.